Zentalis Competitors

ZNTL Stock  USD 18.58  0.13  0.70%   
Zentalis PharmaceuticalsL competes with Siriuspoint, ESGEN Acquisition, Ping An, Palomar Holdings, and Kingsway Financial; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Zentalis PharmaceuticalsL competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Zentalis PharmaceuticalsL to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Zentalis PharmaceuticalsL competition on your existing holdings. Check out Zentalis PharmaceuticalsL Correlation with its peers.
The value of Return on Average Assets is estimated to slide to -0.5. The value of Return on Average Equity is estimated to slide to -0.59. Tangible Assets Book Value per Share is expected to rise to 11.72 this year, although the value of Total Assets will most likely fall to about 456.1 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Zentalis PharmaceuticalsL's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Zentalis PharmaceuticalsL in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
10 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Zentalis PharmaceuticalsL. Your research has to be compared to or analyzed against Zentalis PharmaceuticalsL's peers to derive any actionable benefits. When done correctly, Zentalis PharmaceuticalsL's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Zentalis PharmaceuticalsL.

Zentalis PharmaceuticalsL Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Zentalis PharmaceuticalsL and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Zentalis and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Zentalis PharmaceuticalsL does not affect the price movement of the other competitor.

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Zentalis Stock performing well and Zentalis PharmaceuticalsL company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Zentalis PharmaceuticalsL's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Compare Zentalis PharmaceuticalsL and related stocks such as Siriuspoint, ESGEN Acquisition Corp, Ping An Insurance, Palomar Holdings, Kingsway Financial, Papaya Growth Opportunity, and Universal Insurance Net Income Over Time
Select Fundamental

SPNT99.4 M99.4 M99.4 M227.3 M50.4 M(87.4 M)27.6 M277.8 M(317.7 M)200.6 M143.5 M58.1 M(386.8 M)(397 M)
ESAC9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M9.5 M8.5 M8.5 M
PLMR6.6 M6.6 M6.6 M6.6 M6.6 M6.6 M6.6 M3.8 M18.2 M10.6 M6.3 M45.8 M52.2 M56.3 M
KFS(52.1 M)(52.1 M)(52.1 M)(36.9 M)(12.8 M)1.1 M803 K(15.7 M)(30.1 M)(5.9 M)(6.7 M)(342 K)24.7 M26.7 M
PPYA(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(33 K)(29.7 K)(32 K)
UVE30.3 M30.3 M30.3 M59 M73 M106.5 M99.4 M106.9 M117.1 M46.5 M19.1 M20.4 M(22.3 M)(22.8 M)

Zentalis PharmaceuticalsL and related stocks such as Siriuspoint, ESGEN Acquisition Corp, Ping An Insurance, Palomar Holdings, Kingsway Financial, Papaya Growth Opportunity, and Universal Insurance Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Zentalis PharmaceuticalsL financial statement analysis. It represents the amount of money remaining after all of Zentalis PharmaceuticalsLlc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Zentalis PharmaceuticalsL Competitive Analysis

The better you understand Zentalis PharmaceuticalsL competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Zentalis PharmaceuticalsL's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Zentalis PharmaceuticalsL's competition over several years is one of the best ways to analyze its investment potential.
 Better Than Average     
 Worse Than Peers    View Performance Chart
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
Current Valuation
Cash Flow from Operations
Operating Margin
Retained Earnings
Current Asset
Five Year Return
Price to Book
Shares Outstanding
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Market Capitalization
Price to Sales
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Potential Upside
Treynor Ratio
Maximum Drawdown
Market Risk Adjusted Performance
Risk Adjusted Performance
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Zentalis PharmaceuticalsL Competition Performance Charts

Five steps to successful analysis of Zentalis PharmaceuticalsL Competition

Zentalis PharmaceuticalsL's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Zentalis PharmaceuticalsL in relation to its competition. Zentalis PharmaceuticalsL's competition analysis typically involves several steps, including::
  • Identifying the key players in the market: This involves identifying the major competitors of Zentalis PharmaceuticalsL in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Zentalis PharmaceuticalsL's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Zentalis PharmaceuticalsL, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Zentalis PharmaceuticalsL position

In addition to having Zentalis PharmaceuticalsL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Industrial Metal Mining Thematic Idea Now

Industrial Metal Mining
Industrial Metal Mining Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Industrial Metal Mining Theme or any other thematic opportunities.
View All  Next Launch
Check out Zentalis PharmaceuticalsL Correlation with its peers. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for analysis

When running Zentalis PharmaceuticalsL price analysis, check to measure Zentalis PharmaceuticalsL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zentalis PharmaceuticalsL is operating at the current time. Most of Zentalis PharmaceuticalsL's value examination focuses on studying past and present price action to predict the probability of Zentalis PharmaceuticalsL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zentalis PharmaceuticalsL's price. Additionally, you may evaluate how the addition of Zentalis PharmaceuticalsL to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Zentalis PharmaceuticalsL's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis PharmaceuticalsL. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis PharmaceuticalsL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Return On Assets
Return On Equity
The market value of Zentalis PharmaceuticalsL is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis PharmaceuticalsL's value that differs from its market value or its book value, called intrinsic value, which is Zentalis PharmaceuticalsL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis PharmaceuticalsL's market value can be influenced by many factors that don't directly affect Zentalis PharmaceuticalsL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis PharmaceuticalsL's value and its price as these two are different measures arrived at by different means. Investors typically determine Zentalis PharmaceuticalsL value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis PharmaceuticalsL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.